Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: medicine (2)
nutraceuticals
medicine
press clippings
perriman
NCT
Vanity Fair: Inside NCTx - How A Rare Plant-Derived Molecule Is Turning Fat Into A Boost Of Energy
November 26, 2025
investor
nutraceuticals
medicine
press clippings
cannabinoids
LA Weekly: The Enzyme Frontier - eXoZymes Unlocks a New Era for Cannabinoid Nutraceuticals and Pharma
November 20, 2025
heltzen
investor
nutraceuticals
medicine
press clippings
video
NCT
cannabinoids
'The Upside' interview: Michael Heltzen & Lou Basenese
November 18, 2025
press release
investor
nutraceuticals
medicine
science
eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturing
June 26, 2025
press release
investor
nutraceuticals
medicine
science
ARCHIVE
ARCHIVE: eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
May 6, 2025
Previous page
Page 2 of 2
Next page